Metabolite Biomarkers of <i>Leishmania</i> Antimony Resistance
<i>Leishmania</i> parasites cause leishmaniasis, one of the most epidemiologically important neglected tropical diseases. <i>Leishmania</i> exhibits a high ability of developing drug resistance, and drug resistance is one of the main threats to public health, as it is associa...
Main Authors: | Sneider Alexander Gutierrez Guarnizo, Zemfira N. Karamysheva, Elkin Galeano, Carlos E. Muskus |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/10/5/1063 |
Similar Items
-
Drug-Induced Lipid Remodeling in <i>Leishmania</i> Parasites
by: Sneider Alexander Gutierrez Guarnizo, et al.
Published: (2021-04-01) -
Development and Characterization of a Semi-Solid Dosage Form of Meglumine Antimoniate for Topical Treatment of Cutaneous Leishmaniasis
by: Diana Berenguer, et al.
Published: (2019-11-01) -
Biodistribution of meglumine antimoniate in healthy and Leishmania (Leishmania) infantum chagasi-infected BALB/c mice
by: Samanta Etel Treiger Borborema, et al.
Published: (2013-08-01) -
Pharmacokinetics of neutron-irradiated meglumine antimoniate in Leishmania amazonensis-infected BALB/c mice
by: Samanta Etel Treiger Borborema, et al.
Published: (2019-03-01) -
Establishing a Metabolite Extraction Method to Study the Metabolome of <i>Blastocystis</i> Using NMR
by: Jamie M. Newton, et al.
Published: (2021-05-01)